Judith Branger

2.4k citations

29 papers · 1.6k indexed · h-index 20

Immunology top 5%
- Immune Response and Inflammation 10
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 4
Microbiology top 5%
Applied Microbiology and Biotechnology top 5%
- Antibiotic Use and Resistance 3
Epidemiology top 5%
- Pneumonia and Respiratory Infections 5
Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 2
Infectious Diseases
- Tuberculosis Research and Epidemiology 2
Molecular Biology
- Melanoma and MAPK Pathways 2
Clinical Biochemistry
- Bacterial Identification and Susceptibility Testing 2

Co-authors: Tom van der Poll Sandrine Florquin Sander J. H. van Deventer Peter Speelman Sebastiaan Weijer Sylvia Knapp Jennie M. Pater Jaklien C. Leemans
Cited by: Immunology Microbiology Applied Microbiology and Biotechnology
Journals: The Journal of Immunology (3 papers)Clinical Microbiology and Infection (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)
Partner nations: Netherlands Vietnam United States

In The Last Decade

Judith Branger

29 papers receiving 1.5k citations

Peers

Countries citing papers authored by Judith Branger

Since Specialization

Citations

This map shows the geographic impact of Judith Branger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Branger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Branger more than expected).

Fields of papers citing papers by Judith Branger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Branger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Branger. The network helps show where Judith Branger may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Judith Branger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Judith Branger Line = papers co-authored together Judith Branger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Improving indicator-condition guided testing for HIV in the hospital setting (PROTEST 2·0): A multicenter, interrupted time-series analysis The Lancet Regional Health - Europe ·K. Samson Paul,Maarten F. Schim van der Loeff,Anders Boyd,Udi Davidovich,Marc van der Valk,Kees Brinkman,Kim Sigaloff,Judith Branger,ประพิศลา เทพสิทธา,Godelieve J. de Bree,Peter Reiss,Jan van Bergen,Suzanne E. Geerlings	2022	10
2	Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial Clinical Microbiology and Infection ·Duncan R Cranendonk,Brent C. Opmeer,Michiel A. van Agtmael,Judith Branger,Kees Brinkman,Andy I. M. Hoepelman,Fanny N. Lauw,Jan Jelrik Oosterheert,Annemarie H Pijlman,Sanjay U. C. Sankatsing,Robin Soetekouw,Jan A. Veenstra,Peter J. de Vries,Jan M. Prins,W. Joost Wiersinga	2019	31
3	Effect of an antibiotic checklist on length of hospital stay and appropriate antibiotic use in adult patients treated with intravenous antibiotics: a stepped wedge cluster randomized trial Clinical Microbiology and Infection ·А.М. Цалкович,Jan M. Prins,Brent C. Opmeer,Marja A. Boermeester,Caroline E. Visser,Reinier M. van Hest,Judith Branger,Eva Mattsson,Cláudio Kracker,Nelson González Martínez,D.A. Johnson,O H Mills,邢文会,Michiel A. van Agtmael,Marlies Hulscher,Suzanne E. Geerlings	2017	22
4	High Incidence of Asymptomatic Syphilis in HIV-Infected MSM Justifies Routine Screening Sexually Transmitted Diseases ·Judith Branger,Jan T. M. van der Meer,R J van Ketel,Suzanne Jurriaans,Jan M. Prins	2009	74
5	Lipopolysaccharide binding protein-deficient mice have a normal defense against pulmonary mycobacterial infection Clinical Immunology ·Judith Branger,Jaklien C. Leemans,Sandrine Florquin,Peter Speelman,Douglas T. Golenbock,Esley Torres	2005	9
6	LPS-binding protein-deficient mice have an impaired defense against Gram-negative but not Gram-positive pneumonia International Immunology ·Judith Branger	2004	32
7	Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice International Immunology ·Judith Branger	2004	96
8	PLATELET-ACTIVATING FACTOR RECEPTOR-DEFICIENT MICE SHOW AN UNALTERED CLEARANCE OF NONTYPEABLE HAEMOPHILUS INFLUENZAE FROM THEIR RESPIRATORY TRACT Shock ·Judith Branger,Catharina W. Wieland,Sandrine Florquin,Nico A. Maris,Jennie M. Pater,Peter Speelman,Takao Shimizu,Satoshi Ishii,Tom van der Poll	2004	16
9	P38 Mitogen Activated Protein Kinase Is Involved in the Downregulation of Granulocyte CXC Chemokine Receptors 1 and 2 During Human Endotoxemia Journal of Clinical Immunology ·Bernt van den Blink,Judith Branger,Sebastiaan Weijer,Abhya Gupta,Sander J. H. van Deventer,Maikel P. Peppelenbosch,Tom van der Poll	2004	17
10	Alveolar Macrophages Have a Protective Antiinflammatory Role during Murine Pneumococcal Pneumonia American Journal of Respiratory and Critical Care Medicine ·Sylvia Knapp,Jaklien C. Leemans,Sandrine Florquin,Judith Branger,Nico A. Maris,Jennie M. Pater,Nico van Rooijen,Tom van der Poll	2003	250
11	Procoagulant protein levels are differentially increased during human endotoxemia Journal of Thrombosis and Haemostasis ·Pieter H. Reitsma,Judith Branger,Bernt van den Blink,Sebastiaan Weijer,Tom van der Poll,Joost C.M. Meijers	2003	35
12	Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia Blood ·Judith Branger,Bernt van den Blink,Sebastiaan Weijer,Abhya Gupta,Sander J. H. van Deventer,C. Erik Hack,Maikel P. Peppelenbosch,Tom van der Poll	2003	66
13	Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia The Journal of Immunology ·Judith Branger,Bernt van den Blink,Sebastiaan Weijer,Jeffrey B. Madwed,Carina L. Bos,Abhya Gupta,Chan‐Loi Yong,Stephen H. Polmar,Dariusz P. Olszyna,C. Erik Hack,Sander J. H. van Deventer,Maikel P. Peppelenbosch,Tom van der Poll	2002	203
14	IL-18 Improves the Early Antimicrobial Host Response to Pneumococcal Pneumonia The Journal of Immunology ·Fanny N. Lauw,Judith Branger,Sandrine Florquin,Peter Speelman,Sander J. H. van Deventer,Shizuo Akira,Tom van der Poll	2002	87
15	Advances in Research of the Inflammatory Response: The Importance of Toll-Like Receptors Wiener Medizinische Wochenschrift ·Sylvia Knapp,Judith Branger,Tom van der Poll	2002	9
16	CXC Chemokine Receptor 2 Contributes to Host Defense in Murine Urinary Tract Infection The Journal of Infectious Diseases ·Dariusz P. Olszyna,Sandrine Florquin,Miguel E. Sewnath,Judith Branger,Peter Speelman,Sander J. H. van Deventer,Robert M. Strieter,Tom van der Poll	2001	46
17	TNF-α Compensates for the Impaired Host Defense of IL-1 Type I Receptor-Deficient Mice During Pneumococcal Pneumonia The Journal of Immunology ·Anita W. Rijneveld,Sandrine Florquin,Judith Branger,Peter Speelman,Sander J. H. van Deventer,Tom van der Poll	2001	103
18	Human Endotoxemia Activates p38 MAP Kinase and p42/44 MAP Kinase, But Not c-Jun N-terminal Kinase Molecular Medicine ·Bernt van den Blink,Judith Branger,Sebastiaan Weijer,Sander J. H. van Deventer,Tom van der Poll,Maikel P. Peppelenbosch	2001	15
19	Healing response to various forms of human demineralized bone matrix in athymic rat cranial defects Journal of Oral and Maxillofacial Surgery ·Mila Zahara,Judith Branger,Heiman Wertheim,Nelson Scarborough	1998	59
20	Growth-Stimulating Effects of Somatomedin-/Insulin-Like Peptides in Snell Dwarf Mice Hormone Research ·Sylvia van Buul‐Offers,C. M. Hoogerbrugge,Judith Branger,明子新見,J. L. Van den Brande	1988	21

About Judith Branger

Judith Branger is a scholar working on Applied Microbiology and Biotechnology, Immunology, Molecular Medicine, Immunology and Allergy and Infectious Diseases, having authored 29 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune Response and Inflammation (10 papers), Pneumonia and Respiratory Infections (5 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), Antibiotic Use and Resistance (3 papers), Tuberculosis Research and Epidemiology (2 papers), Antibiotic Resistance in Bacteria (2 papers), Melanoma and MAPK Pathways (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). The work is most often cited by research in Immunology (640 citations), Microbiology (132 citations), Applied Microbiology and Biotechnology (37 citations), Epidemiology (614 citations) and Molecular Medicine (63 citations). Judith Branger has collaborated with scholars based in Netherlands, Vietnam and United States. Frequent co-authors include Tom van der Poll, Sandrine Florquin, Sander J. H. van Deventer, Peter Speelman, Sebastiaan Weijer, Sylvia Knapp, Jennie M. Pater, Jaklien C. Leemans, Bernt van den Blink and Nico A. Maris. Their work appears in journals such as The Journal of Immunology, Clinical Microbiology and Infection, Journal of Antimicrobial Chemotherapy, International Immunology and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact